Zomedica Corp. Enters Material Definitive Agreement
Ticker: ZOMDF · Form: 8-K · Filed: Nov 19, 2024 · CIK: 1684144
| Field | Detail |
|---|---|
| Company | Zomedica Corp. (ZOMDF) |
| Form Type | 8-K |
| Filed Date | Nov 19, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement
TL;DR
Zomedica just signed a big deal, filing shows. Details to come.
AI Summary
Zomedica Corp. announced on November 15, 2024, that it entered into a material definitive agreement. The company, previously known as Zomedica Pharmaceuticals Corp., is incorporated in Alberta, Canada, and has its principal executive offices in Ann Arbor, Michigan. Further details regarding the agreement are expected to be disclosed in subsequent filings.
Why It Matters
This filing indicates a significant new contract or partnership for Zomedica Corp., which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities, the nature and impact of which are not yet fully disclosed.
Key Players & Entities
- Zomedica Corp. (company) — Registrant
- November 15, 2024 (date) — Date of earliest event reported
- Zomedica Pharmaceuticals Corp. (company) — Former company name
- Alberta, Canada (location) — State or Other Jurisdiction of Incorporation
- Ann Arbor, Michigan (location) — Address of Principal Executive Offices
- 001-38298 (other) — Commission File Number
FAQ
What is the nature of the material definitive agreement entered into by Zomedica Corp.?
The filing states that Zomedica Corp. entered into a material definitive agreement on November 15, 2024, but does not provide specific details about the agreement itself.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on November 15, 2024.
What was Zomedica Corp.'s former company name?
Zomedica Corp.'s former company name was Zomedica Pharmaceuticals Corp.
In which jurisdiction is Zomedica Corp. incorporated?
Zomedica Corp. is incorporated in Alberta, Canada.
What is the address of Zomedica Corp.'s principal executive offices?
Zomedica Corp.'s principal executive offices are located at 100 Phoenix Drive, Suite 125, Ann Arbor, Michigan.
Filing Stats: 642 words · 3 min read · ~2 pages · Grade level 9.5 · Accepted 2024-11-19 17:03:25
Filing Documents
- zom_8k.htm (8-K) — 28KB
- zom_ex101.htm (EX-10.1) — 11KB
- zom_ex101img48.jpg (GRAPHIC) — 267KB
- zom_ex101img46.jpg (GRAPHIC) — 290KB
- zom_ex101img47.jpg (GRAPHIC) — 268KB
- zom_ex101img55.jpg (GRAPHIC) — 255KB
- zom_ex101img49.jpg (GRAPHIC) — 296KB
- zom_ex101img50.jpg (GRAPHIC) — 225KB
- zom_ex101img51.jpg (GRAPHIC) — 49KB
- zom_ex101img52.jpg (GRAPHIC) — 78KB
- zom_ex101img53.jpg (GRAPHIC) — 53KB
- zom_ex101img45.jpg (GRAPHIC) — 338KB
- zom_ex101img44.jpg (GRAPHIC) — 266KB
- zom_8kimg5.jpg (GRAPHIC) — 32KB
- zom_ex101img37.jpg (GRAPHIC) — 146KB
- zom_ex101img38.jpg (GRAPHIC) — 126KB
- zom_ex101img39.jpg (GRAPHIC) — 285KB
- zom_ex101img40.jpg (GRAPHIC) — 295KB
- zom_ex101img41.jpg (GRAPHIC) — 322KB
- zom_ex101img42.jpg (GRAPHIC) — 307KB
- zom_ex101img43.jpg (GRAPHIC) — 304KB
- zom_ex101img54.jpg (GRAPHIC) — 258KB
- 0001654954-24-014663.txt ( ) — 6341KB
- zom-20241115.xsd (EX-101.SCH) — 6KB
- zom-20241115_lab.xml (EX-101.LAB) — 14KB
- zom-20241115_cal.xml (EX-101.CAL) — 1KB
- zom-20241115_pre.xml (EX-101.PRE) — 9KB
- zom-20241115_def.xml (EX-101.DEF) — 2KB
- zom_8k_htm.xml (XML) — 4KB
01. Entry into a Material Definitive Agreement
Item 1.01. Entry into a Material Definitive Agreement. On November 15, 2024, Zomedica, Inc., a wholly-owned subsidiary of Zomedica Corp., entered into a Lease Agreement (the "Lease") with 1101 Technology Drive, L.L.C (the "Landlord") for property located at 1101 Technology Drive, Suite 100, Ann Arbor, MI 48108 (the "Leased Premises"). The Lease will commence on February 1, 2025 and replaces the existing lease with Wickfield Properties LLC for the Company headquarters located at 100 Pheonix Drive, Suite 190, Ann Arbor, MI 48108 which expires on January 31, 2025. The Lease is for 15,371 rentable square feet. The Lease expired on January 31, 2030, but contains two five year options to extend the Lease under substantially the same terms and conditions. Base rent during the initial term will be: In addition to base rent, tenant will be responsible utilities and for its proportionate share of expenses and taxes, subject to an annual cap of 5% over prior year expenses and taxes. The Lease is furnished as Exhibit 10.1 to this current report on Form 8-K and is incorporated herein by reference. The foregoing description of the Lease Amendment does not purport to be complete and is qualified in its entirety by reference to the Lease and the Lease Amendment.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibit No. Description 10.1 Lease Agreement entered into as of November 15, 2024 by and between 1101 Technology Drive, L.L.C. and Zomedica Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZOMEDICA CORP. Date: November 19, 2024 By: /s/ Karen L. DeHaan-Fullerton Karen L. DeHaan-Fullerton General Counsel and Corporate Secretary 3 EXHIBIT INDEX Exhibit No. Description 10.1 Lease Agreement entered into as of November 15, 2024 by and between 1101 Technology Drive, L.L.C. and Zomedica Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 4